SIMILAR PATTERNS OF AMINO ACIDS FOR 4X20_D_LOCD502_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1htd ATROLYSIN C

(Crotalus atrox)
PF01421
(Reprolysin)
5 LEU A  47
LEU A 148
ASN A 147
MET A 116
ILE A 198
None
1.02A 4x20D-1htdA:
undetectable
4x20D-1htdA:
19.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ixx COAGULATION FACTORS
IX/X-BINDING PROTEIN


(Protobothrops
flavoviridis)
PF00059
(Lectin_C)
5 ASN A  58
MET A  59
VAL A  40
LYS A  15
ILE A  66
None
1.13A 4x20D-1ixxA:
undetectable
4x20D-1ixxA:
19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1iy1 ATP-DEPENDENT
METALLOPROTEASE FTSH


(Thermus
thermophilus)
PF00004
(AAA)
5 LEU A 283
LEU A 311
THR A 301
ALA A 299
VAL A 297
None
1.01A 4x20D-1iy1A:
undetectable
4x20D-1iy1A:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1iy2 ATP-DEPENDENT
METALLOPROTEASE FTSH


(Thermus
thermophilus)
PF00004
(AAA)
5 LEU A 283
LEU A 311
THR A 301
ALA A 299
VAL A 297
None
0.95A 4x20D-1iy2A:
undetectable
4x20D-1iy2A:
20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1izo CYTOCHROME P450
152A1


(Bacillus
subtilis)
PF00067
(p450)
5 LEU A 241
LEU A 102
LEU A 214
ALA A 218
ILE A 198
None
1.07A 4x20D-1izoA:
undetectable
4x20D-1izoA:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j1u TYROSYL-TRNA
SYNTHETASE


(Methanocaldococcus
jannaschii)
PF00579
(tRNA-synt_1b)
5 LEU A  24
LEU A  55
MET A  52
VAL A 189
ILE A 191
None
1.09A 4x20D-1j1uA:
undetectable
4x20D-1j1uA:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pp1 P40 NUCLEOPROTEIN

(Borna disease
virus)
PF06407
(BDV_P40)
5 LEU X 144
LEU X 211
ALA X 233
VAL X 229
ILE X 149
None
1.15A 4x20D-1pp1X:
undetectable
4x20D-1pp1X:
20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qjm LACTOFERRIN

(Equus caballus)
PF00405
(Transferrin)
5 LEU A 299
LYS A  21
ASN A  25
MET A  26
ALA A 274
None
1.10A 4x20D-1qjmA:
undetectable
4x20D-1qjmA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rzr GLUCOSE-RESISTANCE
AMYLASE REGULATOR


(Bacillus
megaterium)
no annotation 5 LEU G 234
ASN G 179
ALA G 181
VAL G 217
ILE G 243
None
1.09A 4x20D-1rzrG:
undetectable
4x20D-1rzrG:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vfw PROTEIN (FUSION
PROTEIN CONSISTING
OF KINESIN-LIKE
PROTEIN KIF1A,
KINESIN HEAVY CHAIN
ISOFORM 5C AND A HIS
TAG


(Mus musculus)
PF00225
(Kinesin)
5 MET A  81
ALA A 326
VAL A 328
LYS A   7
ILE A  93
None
1.10A 4x20D-1vfwA:
undetectable
4x20D-1vfwA:
22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wni TRIMERELYSIN II

(Protobothrops
flavoviridis)
PF01421
(Reprolysin)
5 LEU A  47
LEU A 148
ASN A 147
MET A 116
ILE A 197
None
1.07A 4x20D-1wniA:
undetectable
4x20D-1wniA:
16.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yp1 FII

(Deinagkistrodon
acutus)
PF01421
(Reprolysin)
5 LEU A  47
LEU A 148
ASN A 147
MET A 116
ILE A 197
None
0.98A 4x20D-1yp1A:
undetectable
4x20D-1yp1A:
17.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2buc DIPEPTIDYL PEPTIDASE
IV


(Sus scrofa)
PF00326
(Peptidase_S9)
PF00930
(DPPIV_N)
5 LEU A 410
LEU A 436
ASN A 437
LYS A 441
ILE A 397
None
0.90A 4x20D-2bucA:
undetectable
4x20D-2bucA:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cnd NADH-DEPENDENT
NITRATE REDUCTASE


(Zea mays)
PF00175
(NAD_binding_1)
PF00970
(FAD_binding_6)
5 LEU A  17
LEU A  78
LEU A 101
MET A  97
VAL A 112
None
1.16A 4x20D-2cndA:
undetectable
4x20D-2cndA:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dh4 YPL069C

(Saccharomyces
cerevisiae)
PF00348
(polyprenyl_synt)
5 LEU A  47
LEU A 183
LEU A 206
ASN A 204
ILE A 304
None
1.14A 4x20D-2dh4A:
undetectable
4x20D-2dh4A:
22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dhr FTSH

(Thermus
thermophilus)
PF00004
(AAA)
PF01434
(Peptidase_M41)
5 LEU A 283
LEU A 311
ALA A 299
VAL A 297
ILE A 257
None
1.10A 4x20D-2dhrA:
undetectable
4x20D-2dhrA:
21.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dyk GTP-BINDING PROTEIN

(Thermus
thermophilus)
PF01926
(MMR_HSR1)
5 LEU A  17
LEU A  84
VAL A  44
LYS A   3
ILE A 156
None
1.02A 4x20D-2dykA:
5.0
4x20D-2dykA:
16.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ell ACIDIC LEUCINE-RICH
NUCLEAR
PHOSPHOPROTEIN 32
FAMILY MEMBER B


(Homo sapiens)
PF14580
(LRR_9)
5 LEU A 113
LEU A 122
LEU A 102
ASN A 101
ILE A  83
None
1.19A 4x20D-2ellA:
undetectable
4x20D-2ellA:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ell ACIDIC LEUCINE-RICH
NUCLEAR
PHOSPHOPROTEIN 32
FAMILY MEMBER B


(Homo sapiens)
PF14580
(LRR_9)
5 LEU A 116
LEU A  97
LEU A 102
ASN A 101
ILE A  83
None
1.18A 4x20D-2ellA:
undetectable
4x20D-2ellA:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ewy BETA-SECRETASE 2

(Homo sapiens)
PF00026
(Asp)
5 LEU A 343
LEU A 300
LEU A 219
VAL A 349
ILE A 296
None
1.19A 4x20D-2ewyA:
undetectable
4x20D-2ewyA:
22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f7l 455AA LONG
HYPOTHETICAL
PHOSPHO-SUGAR MUTASE


(Sulfurisphaera
tokodaii)
PF00408
(PGM_PMM_IV)
PF02878
(PGM_PMM_I)
PF02879
(PGM_PMM_II)
PF02880
(PGM_PMM_III)
5 LEU A 348
LYS A 273
ASN A 274
ALA A 323
ILE A 281
None
1.18A 4x20D-2f7lA:
undetectable
4x20D-2f7lA:
21.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gas ISOFLAVONE REDUCTASE

(Medicago sativa)
PF05368
(NmrA)
5 LEU A  10
THR A  80
ALA A  84
VAL A  88
ILE A  85
None
1.10A 4x20D-2gasA:
6.9
4x20D-2gasA:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2i6e HYPOTHETICAL PROTEIN

(Deinococcus
radiodurans)
PF02621
(VitK2_biosynth)
5 LEU A 220
LEU A  34
ASN A  63
ALA A  19
VAL A  40
None
1.08A 4x20D-2i6eA:
undetectable
4x20D-2i6eA:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ix5 ACYL-COENZYME A
OXIDASE 4,
PEROXISOMAL


(Arabidopsis
thaliana)
PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
5 LEU A 284
LEU A 174
THR A 188
VAL A 274
ILE A 227
CAA  A1432 (-4.2A)
FAD  A1433 (-4.4A)
None
None
None
1.06A 4x20D-2ix5A:
undetectable
4x20D-2ix5A:
23.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2kzf RIBOSOME-BINDING
FACTOR A


(Thermotoga
maritima)
PF02033
(RBFA)
5 LEU A  18
LEU A  11
ALA A  50
VAL A  41
ILE A  93
None
1.03A 4x20D-2kzfA:
undetectable
4x20D-2kzfA:
16.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qz4 PARAPLEGIN

(Homo sapiens)
PF00004
(AAA)
5 LEU A 437
LEU A 465
THR A 455
ALA A 453
VAL A 451
None
1.15A 4x20D-2qz4A:
undetectable
4x20D-2qz4A:
20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2va0 ABFS
ARABINOFURANOSIDASE
TWO COMPONENT SYSTEM
SENSOR PROTEIN


(Cellvibrio
japonicus)
no annotation 5 LEU A  95
LEU A 134
ASN A 138
VAL A 142
ILE A 132
None
None
None
None
CL  A1149 ( 4.6A)
1.14A 4x20D-2va0A:
undetectable
4x20D-2va0A:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vxo GMP SYNTHASE
[GLUTAMINE-HYDROLYZI
NG]


(Homo sapiens)
PF00117
(GATase)
PF00958
(GMP_synt_C)
PF02540
(NAD_synthase)
5 LEU A 411
LEU A 426
ASN A 257
ALA A 259
ILE A 230
None
1.10A 4x20D-2vxoA:
undetectable
4x20D-2vxoA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w21 GLUTAMATE 5-KINASE

(Escherichia
coli)
PF00696
(AA_kinase)
5 LEU A 155
LEU A 121
ALA A 162
VAL A   8
ILE A 229
None
1.15A 4x20D-2w21A:
undetectable
4x20D-2w21A:
18.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wcu PROTEIN FUCU HOMOLOG

(Mus musculus)
PF05025
(RbsD_FucU)
5 LEU A  11
LEU A  19
MET A  22
VAL A 130
ILE A  28
None
1.09A 4x20D-2wcuA:
undetectable
4x20D-2wcuA:
15.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xe4 OLIGOPEPTIDASE B

(Leishmania
major)
PF00326
(Peptidase_S9)
PF02897
(Peptidase_S9_N)
5 LEU A 688
LEU A 598
THR A 724
ALA A 715
ILE A  79
None
PGR  A1742 (-4.0A)
None
None
None
1.15A 4x20D-2xe4A:
undetectable
4x20D-2xe4A:
19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ygt DELTA TOXIN

(Clostridium
perfringens)
PF07968
(Leukocidin)
5 LYS A 239
LEU A 279
ALA A  48
VAL A  46
ILE A  63
None
1.11A 4x20D-2ygtA:
undetectable
4x20D-2ygtA:
22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a1j CELL CYCLE
CHECKPOINT PROTEIN
RAD1


(Homo sapiens)
PF02144
(Rad1)
5 LEU C  90
LEU C  27
ALA C  63
VAL C  51
ILE C  34
None
1.15A 4x20D-3a1jC:
undetectable
4x20D-3a1jC:
18.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b2d CD180 ANTIGEN

(Homo sapiens)
PF00560
(LRR_1)
PF13855
(LRR_8)
5 LEU A 377
LEU A 395
LEU A 350
ALA A 341
ILE A 339
None
1.02A 4x20D-3b2dA:
undetectable
4x20D-3b2dA:
20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ber PROBABLE
ATP-DEPENDENT RNA
HELICASE DDX47


(Homo sapiens)
PF00270
(DEAD)
5 LEU A 192
LEU A 220
LEU A 215
ALA A 176
ILE A 179
PGE  A 401 (-3.9A)
None
None
None
None
1.14A 4x20D-3berA:
undetectable
4x20D-3berA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dsl ZINC
METALLOPROTEINASE-DI
SINTEGRIN
BOTHROPASIN


(Bothrops
jararaca)
PF00200
(Disintegrin)
PF01421
(Reprolysin)
PF08516
(ADAM_CR)
5 LEU A  50
LEU A 151
ASN A 150
MET A 119
ILE A 201
None
1.05A 4x20D-3dslA:
undetectable
4x20D-3dslA:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h1g CHEMOTAXIS PROTEIN
CHEY HOMOLOG


(Helicobacter
pylori)
PF00072
(Response_reg)
5 LEU A  64
LYS A  40
LEU A  41
ASN A  44
ILE A  77
None
0.97A 4x20D-3h1gA:
4.9
4x20D-3h1gA:
15.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h5c PROTEIN Z-DEPENDENT
PROTEASE INHIBITOR


(Homo sapiens)
PF00079
(Serpin)
5 LEU A 299
LEU A 304
ASN A 306
MET A 307
VAL A 280
None
1.17A 4x20D-3h5cA:
undetectable
4x20D-3h5cA:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ig4 XAA-PRO
AMINOPEPTIDASE


(Bacillus
anthracis)
PF00557
(Peptidase_M24)
PF05195
(AMP_N)
5 LEU A 207
LEU A 195
ASN A 416
MET A 412
ILE A 408
None
1.18A 4x20D-3ig4A:
undetectable
4x20D-3ig4A:
21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j4s FTSZ/TUBULIN-RELATED
PROTEIN


(Bacillus
thuringiensis)
PF00091
(Tubulin)
5 LEU A 388
LEU A 183
THR A 143
ALA A 137
ILE A 166
None
1.16A 4x20D-3j4sA:
20.4
4x20D-3j4sA:
22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jb9 SMALL NUCLEAR
RIBONUCLEOPROTEIN SM
D2


(Schizosaccharomyces
pombe)
PF01423
(LSM)
5 LEU G 101
ASN G  65
MET G  66
VAL G 107
ILE G  45
None
U  C 101 ( 3.2A)
None
None
None
1.13A 4x20D-3jb9G:
undetectable
4x20D-3jb9G:
14.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k53 FERROUS IRON
TRANSPORT PROTEIN B


(Pyrococcus
furiosus)
PF02421
(FeoB_N)
5 ASN A  81
THR A   5
ALA A   7
VAL A   9
ILE A  85
None
0.93A 4x20D-3k53A:
4.6
4x20D-3k53A:
20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3m5r NONSTRUCTURAL
PROTEIN 1


(Influenza A
virus)
PF00600
(Flu_NS1)
5 LEU A 181
LEU A 115
LEU A 147
ALA A 202
ILE A 198
None
1.14A 4x20D-3m5rA:
undetectable
4x20D-3m5rA:
15.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mha LIPOPROTEIN LPRG

(Mycobacterium
tuberculosis)
PF07161
(LppX_LprAFG)
5 LEU A 111
THR A 116
ALA A 102
VAL A  91
ILE A 100
Z69  A   1 ( 4.8A)
None
Z69  A   1 ( 4.9A)
Z69  A   1 (-4.8A)
None
0.97A 4x20D-3mhaA:
undetectable
4x20D-3mhaA:
19.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mvk PROTEIN FUCU

(Bifidobacterium
longum)
PF05025
(RbsD_FucU)
5 LEU A  60
LEU A  17
LYS A 141
LEU A 139
ILE A  28
None
1.10A 4x20D-3mvkA:
undetectable
4x20D-3mvkA:
17.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mw8 UROPORPHYRINOGEN-III
SYNTHASE


(Shewanella
amazonensis)
PF02602
(HEM4)
5 LEU A 109
LEU A 114
THR A  76
VAL A  80
ILE A  54
None
1.12A 4x20D-3mw8A:
undetectable
4x20D-3mw8A:
21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oc4 OXIDOREDUCTASE,
PYRIDINE
NUCLEOTIDE-DISULFIDE
FAMILY


(Enterococcus
faecalis)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 LEU A  -1
LEU A 309
ASN A 307
ALA A  15
ILE A 106
None
1.18A 4x20D-3oc4A:
undetectable
4x20D-3oc4A:
21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rg1 CD180 MOLECULE

(Bos taurus)
PF00560
(LRR_1)
PF13855
(LRR_8)
5 LEU A 377
LEU A 395
LEU A 350
ALA A 341
ILE A 339
None
1.03A 4x20D-3rg1A:
undetectable
4x20D-3rg1A:
21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t6q CD180 ANTIGEN

(Mus musculus)
PF13855
(LRR_8)
5 LEU A 377
LEU A 395
LEU A 350
ALA A 341
ILE A 339
None
0.98A 4x20D-3t6qA:
undetectable
4x20D-3t6qA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tfw PUTATIVE
O-METHYLTRANSFERASE


(Klebsiella
pneumoniae)
PF01596
(Methyltransf_3)
5 LEU A 151
THR A 218
ALA A 220
VAL A 222
ILE A 164
None
1.02A 4x20D-3tfwA:
3.9
4x20D-3tfwA:
20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v8v RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE L


(Escherichia
coli)
PF01170
(UPF0020)
PF02926
(THUMP)
PF10672
(Methyltrans_SAM)
5 LEU A  43
LEU A  20
THR A   8
ALA A   6
ILE A  57
None
1.17A 4x20D-3v8vA:
3.5
4x20D-3v8vA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vs8 TYPE III POLYKETIDE
SYNTHASE


(Azotobacter
vinelandii)
PF02797
(Chal_sti_synt_C)
5 LEU A 377
LEU A 404
MET A 270
VAL A 251
ILE A 267
None
1.16A 4x20D-3vs8A:
undetectable
4x20D-3vs8A:
21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3whl PROTEASOME-ACTIVATIN
G NUCLEOTIDASE, 26S
PROTEASE REGULATORY
SUBUNIT 6A


(Pyrococcus
furiosus;
Saccharomyces
cerevisiae)
PF00004
(AAA)
5 LEU A 309
LEU A 337
THR A 327
ALA A 325
VAL A 323
LEU  A 309 ( 0.6A)
LEU  A 337 ( 0.6A)
THR  A 327 ( 0.8A)
ALA  A 325 ( 0.0A)
VAL  A 323 ( 0.6A)
0.93A 4x20D-3whlA:
undetectable
4x20D-3whlA:
22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3whl PROTEASOME-ACTIVATIN
G NUCLEOTIDASE, 26S
PROTEASE REGULATORY
SUBUNIT 6A


(Pyrococcus
furiosus;
Saccharomyces
cerevisiae)
PF00004
(AAA)
5 LEU A 309
THR A 327
ALA A 325
VAL A 323
ILE A 280
LEU  A 309 ( 0.6A)
THR  A 327 ( 0.8A)
ALA  A 325 ( 0.0A)
VAL  A 323 ( 0.6A)
ILE  A 280 ( 0.7A)
1.09A 4x20D-3whlA:
undetectable
4x20D-3whlA:
22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a2q RETINOIC ACID
INDUCIBLE PROTEIN I


(Anas
platyrhynchos)
PF00270
(DEAD)
PF00271
(Helicase_C)
PF16739
(CARD_2)
5 LEU A 612
LEU A 619
LEU A 644
THR A 698
VAL A 742
None
1.13A 4x20D-4a2qA:
undetectable
4x20D-4a2qA:
20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a2w RETINOIC ACID
INDUCIBLE PROTEIN I


(Anas
platyrhynchos)
PF00270
(DEAD)
PF00271
(Helicase_C)
PF16739
(CARD_2)
5 LEU A 612
LEU A 619
LEU A 644
THR A 698
VAL A 742
None
1.13A 4x20D-4a2wA:
undetectable
4x20D-4a2wA:
17.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4buj ANTIVIRAL HELICASE
SKI2


(Saccharomyces
cerevisiae)
PF00270
(DEAD)
PF00271
(Helicase_C)
PF08148
(DSHCT)
5 LEU A1150
LEU A1171
ALA A1219
VAL A1215
ILE A1275
None
1.06A 4x20D-4bujA:
undetectable
4x20D-4bujA:
16.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e69 2-DEHYDRO-3-DEOXYGLU
CONOKINASE


(Oceanicola
granulosus)
PF00294
(PfkB)
5 LEU A  37
LEU A 262
ALA A 159
VAL A 125
ILE A 188
None
0.91A 4x20D-4e69A:
5.5
4x20D-4e69A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fid G PROTEIN ALPHA
SUBUNIT


(Entamoeba
histolytica)
PF00503
(G-alpha)
5 LEU A 250
ASN A 347
MET A 348
VAL A  26
ILE A  24
None
0.99A 4x20D-4fidA:
2.9
4x20D-4fidA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4h41 PUTATIVE
ALPHA-L-FUCOSIDASE


(Bacteroides
thetaiotaomicron)
PF14488
(DUF4434)
PF17134
(DUF5109)
5 LEU A 355
LYS A 318
LEU A 319
THR A 298
ILE A  60
None
1.15A 4x20D-4h41A:
3.3
4x20D-4h41A:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4i3u ALDEHYDE
DEHYDROGENASE (NAD+)


(Sinorhizobium
meliloti)
PF00171
(Aldedh)
5 LEU A 202
ASN A 175
ALA A 171
VAL A 168
ILE A 151
None
1.15A 4x20D-4i3uA:
undetectable
4x20D-4i3uA:
23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4j4m ZINC-DEPENDENT
METALLOPROTEINASE


(Protobothrops
mucrosquamatus)
PF01421
(Reprolysin)
5 LEU A  49
LEU A 150
ASN A 149
MET A 118
ILE A 199
None
1.05A 4x20D-4j4mA:
undetectable
4x20D-4j4mA:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mhl INTERLEUKIN-11

(Homo sapiens)
PF07400
(IL11)
5 LEU A  78
LEU A  75
ASN A  71
ALA A 176
ILE A 177
None
1.15A 4x20D-4mhlA:
undetectable
4x20D-4mhlA:
19.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qmk TYPE III SECRETION
SYSTEM EFFECTOR
PROTEIN EXOU


(Pseudomonas
fluorescens)
PF01734
(Patatin)
5 LEU A 441
LEU A 448
ASN A 450
VAL A  30
ILE A  37
None
1.08A 4x20D-4qmkA:
undetectable
4x20D-4qmkA:
23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r5c LEUCINE RICH REPEAT
PROTEIN


(synthetic
construct)
PF12354
(Internalin_N)
PF12799
(LRR_4)
PF13516
(LRR_6)
PF13855
(LRR_8)
5 LEU A 147
LEU A 192
ASN A 186
THR A 184
VAL A 199
None
1.13A 4x20D-4r5cA:
undetectable
4x20D-4r5cA:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r7z CELL DIVISION
CONTROL PROTEIN 21


(Pyrococcus
furiosus)
PF00493
(MCM)
5 LEU A 325
LEU A 338
LEU A 761
MET A 764
ILE A 772
None
1.04A 4x20D-4r7zA:
undetectable
4x20D-4r7zA:
22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uer EIF3B

(Lachancea
kluyveri)
PF00318
(Ribosomal_S2)
5 LEU b 603
ALA b 651
VAL b 649
LYS b 665
ILE b 640
None
0.92A 4x20D-4uerb:
undetectable
4x20D-4uerb:
20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uzy FLAGELLAR ASSOCIATED
PROTEIN


(Chlamydomonas
reinhardtii)
PF12895
(ANAPC3)
PF13174
(TPR_6)
5 LEU A 453
LEU A 495
ASN A 494
ALA A 469
ILE A 470
None
1.17A 4x20D-4uzyA:
undetectable
4x20D-4uzyA:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xjn NUCLEOCAPSID

(Mammalian
rubulavirus 5)
PF00973
(Paramyxo_ncap)
5 LEU A  73
THR A 178
ALA A 174
VAL A 170
ILE A 219
None
0.98A 4x20D-4xjnA:
undetectable
4x20D-4xjnA:
21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z1p CELL WALL SURFACE
ANCHOR PROTEIN


(Streptococcus
agalactiae)
PF16364
(Antigen_C)
5 LEU A  90
LEU A  97
ALA A  50
VAL A  52
ILE A 155
None
1.08A 4x20D-4z1pA:
undetectable
4x20D-4z1pA:
21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zem TRANSLATION
INITIATION FACTOR
EIF2B-LIKE
PROTEIN,TRANSLATION
INITIATION FACTOR
EIF2B-LIKE PROTEIN


(Chaetomium
thermophilum)
PF01008
(IF-2B)
5 LEU A 265
LYS A 228
ALA A 223
VAL A 245
ILE A 295
None
1.13A 4x20D-4zemA:
3.1
4x20D-4zemA:
22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cyr RNA-DEPENDENT RNA
POLYMERASE


(Thosea asigna
virus)
no annotation 5 LEU B 517
LEU B 513
LEU B 329
MET B 307
ALA B 347
None
1.18A 4x20D-5cyrB:
undetectable
4x20D-5cyrB:
21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e78 BIFUNCTIONAL
P-450/NADPH-P450
REDUCTASE


(Bacillus
megaterium)
PF00067
(p450)
5 LEU A 298
LEU A 412
THR A 152
ALA A 123
VAL A 127
None
1.04A 4x20D-5e78A:
undetectable
4x20D-5e78A:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e7p CELL DIVISION
CONTROL PROTEIN
CDC48


(Mycolicibacterium
smegmatis)
PF00004
(AAA)
PF02359
(CDC48_N)
5 LEU A 454
LEU A 439
ALA A 166
VAL A 169
ILE A 171
None
1.16A 4x20D-5e7pA:
undetectable
4x20D-5e7pA:
20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eqt PROTEASOME-ACTIVATIN
G NUCLEOTIDASE


(Pyrococcus
horikoshii)
PF00004
(AAA)
5 LEU A 234
LEU A 262
THR A 252
ALA A 250
VAL A 248
None
0.88A 4x20D-5eqtA:
undetectable
4x20D-5eqtA:
22.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eqt PROTEASOME-ACTIVATIN
G NUCLEOTIDASE


(Pyrococcus
horikoshii)
PF00004
(AAA)
5 LEU A 234
THR A 252
ALA A 250
VAL A 248
ILE A 205
None
1.11A 4x20D-5eqtA:
undetectable
4x20D-5eqtA:
22.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fn4 NICASTRIN

(Homo sapiens)
PF05450
(Nicastrin)
5 LEU A 312
LEU A 494
THR A 280
ALA A 278
VAL A 276
None
0.87A 4x20D-5fn4A:
4.3
4x20D-5fn4A:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g06 EXOSOME COMPLEX
COMPONENT RRP42


(Saccharomyces
cerevisiae)
PF01138
(RNase_PH)
PF03725
(RNase_PH_C)
5 LEU E 103
LEU E 149
ASN E 150
VAL E  60
ILE E  62
None
1.12A 4x20D-5g06E:
undetectable
4x20D-5g06E:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g4l OXIDOREDUCTASE,
SHORT CHAIN
DEHYDROGENASE/REDUCT
ASE FAMILY PROTEIN


(Clostridium sp.)
PF13561
(adh_short_C2)
5 LEU A  33
LEU A 240
ALA A  42
VAL A  44
LYS A  18
None
1.15A 4x20D-5g4lA:
6.9
4x20D-5g4lA:
19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gl7 METHIONINE--TRNA
LIGASE, CYTOPLASMIC


(Homo sapiens)
PF09334
(tRNA-synt_1g)
5 LEU A 786
LEU A 689
LEU A 782
VAL A 754
ILE A 780
None
1.05A 4x20D-5gl7A:
undetectable
4x20D-5gl7A:
20.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h6o PORPHOBILINOGEN
DEAMINASE


(Vibrio cholerae)
no annotation 5 LEU A 244
ASN A 241
MET A 240
ALA A 267
VAL A 278
None
1.14A 4x20D-5h6oA:
undetectable
4x20D-5h6oA:
22.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5mjs TUBULIN BETA CHAIN

(Schizosaccharomyces
pombe)
no annotation 5 LEU A 253
MET A 257
THR A 311
ALA A 313
ILE A 367
None
1.12A 4x20D-5mjsA:
53.0
4x20D-5mjsA:
58.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5mjs TUBULIN BETA CHAIN

(Schizosaccharomyces
pombe)
no annotation 5 LYS A 252
MET A 257
THR A 311
ALA A 313
ILE A 367
None
1.17A 4x20D-5mjsA:
53.0
4x20D-5mjsA:
58.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n5n TUBULIN BETA CHAIN

(Homo sapiens)
no annotation 5 LEU B 252
THR B 314
ALA B 316
VAL B 318
ILE B 378
None
1.04A 4x20D-5n5nB:
53.4
4x20D-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n5n TUBULIN BETA CHAIN

(Homo sapiens)
no annotation 5 LEU B 255
ASN B 258
MET B 259
THR B 314
ILE B 378
None
0.98A 4x20D-5n5nB:
53.4
4x20D-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n5n TUBULIN BETA CHAIN

(Homo sapiens)
no annotation 5 LEU B 255
MET B 259
THR B 314
ALA B 316
ILE B 378
None
1.06A 4x20D-5n5nB:
53.4
4x20D-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n5n TUBULIN BETA CHAIN

(Homo sapiens)
no annotation 5 LYS B 254
ASN B 258
MET B 259
THR B 314
ILE B 378
None
0.77A 4x20D-5n5nB:
53.4
4x20D-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n5n TUBULIN BETA CHAIN

(Homo sapiens)
no annotation 5 MET B 259
THR B 314
ALA B 316
VAL B 318
ILE B 378
None
0.77A 4x20D-5n5nB:
53.4
4x20D-5n5nB:
97.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5swv PENTAFUNCTIONAL AROM
POLYPEPTIDE


(Schizosaccharomyces
pombe)
PF01487
(DHquinase_I)
PF08501
(Shikimate_dh_N)
5 LYS C1338
LEU C1340
ALA C1348
VAL C1350
ILE C1378
None
0.84A 4x20D-5swvC:
undetectable
4x20D-5swvC:
21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t67 SUGAR 3-C-METHYL
TRANSFERASE


(Actinomadura
kijaniata)
PF08421
(Methyltransf_13)
PF08484
(Methyltransf_14)
PF13489
(Methyltransf_23)
5 LEU A 185
ASN A 177
ALA A 175
VAL A 202
ILE A 112
None
SAH  A 502 ( 3.7A)
None
None
SAH  A 502 (-4.4A)
1.09A 4x20D-5t67A:
2.9
4x20D-5t67A:
22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tvj ENHANCED
INTRACELLULAR
SURVIVAL PROTEIN


(Mycobacterium
tuberculosis)
PF13527
(Acetyltransf_9)
PF13530
(SCP2_2)
6 LEU A 217
LEU A 259
MET A 262
ALA A 236
VAL A 238
ILE A 265
None
1.41A 4x20D-5tvjA:
undetectable
4x20D-5tvjA:
20.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5w3j TUBULIN BETA CHAIN

(Saccharomyces
cerevisiae)
PF00091
(Tubulin)
PF03953
(Tubulin_C)
5 LEU B 253
ASN B 256
THR B 312
ALA B 314
ILE B 368
None
0.87A 4x20D-5w3jB:
53.2
4x20D-5w3jB:
75.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wkn NUCLEOPROTEIN

(Mammalian
rubulavirus 5)
no annotation 5 LEU A  73
THR A 178
ALA A 174
VAL A 170
ILE A 219
None
1.08A 4x20D-5wknA:
undetectable
4x20D-5wknA:
12.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xa2 CYSTEINE SYNTHASE

(Planctopirus
limnophila)
PF00291
(PALP)
5 LEU A 255
MET A 271
ALA A  32
VAL A  17
ILE A  19
None
1.11A 4x20D-5xa2A:
undetectable
4x20D-5xa2A:
21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b5c KATANIN P60
ATPASE-CONTAINING
SUBUNIT A-LIKE 1


(Homo sapiens)
no annotation 5 LEU A 333
LEU A 368
THR A 358
ALA A 356
VAL A 354
None
0.88A 4x20D-6b5cA:
undetectable
4x20D-6b5cA:
12.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b5c KATANIN P60
ATPASE-CONTAINING
SUBUNIT A-LIKE 1


(Homo sapiens)
no annotation 5 LEU A 333
THR A 358
ALA A 356
VAL A 354
ILE A 306
None
1.15A 4x20D-6b5cA:
undetectable
4x20D-6b5cA:
12.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bf6 INSULIN-DEGRADING
ENZYME


(Homo sapiens)
no annotation 6 LEU A 642
LEU A 616
LEU A 574
ASN A 573
LYS A 571
ILE A 733
None
1.28A 4x20D-6bf6A:
undetectable
4x20D-6bf6A:
12.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c9e CYSTEINE DESULFURASE

(Legionella
pneumophila)
no annotation 5 LYS A 168
LEU A 169
ASN A 170
ALA A 203
VAL A 205
None
1.18A 4x20D-6c9eA:
undetectable
4x20D-6c9eA:
12.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c9m N-ALPHA-ACETYLTRANSF
ERASE 10
N-ALPHA-ACETYLTRANSF
ERASE 15, NATA
AUXILIARY SUBUNIT


(Homo sapiens)
no annotation 5 LEU A 541
LEU B  11
ASN B  13
MET B  14
ALA B   6
None
0.99A 4x20D-6c9mA:
undetectable
4x20D-6c9mA:
10.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6e29 -

(-)
no annotation 5 LEU D  92
LEU D  95
ASN D  33
ALA D  40
VAL D  48
None
1.09A 4x20D-6e29D:
undetectable
4x20D-6e29D:
undetectable